Praecis Pharmaceuticals

Praecis Pharmaceuticals (NASDAQ: PRCS) is a biotechnology company focused on the discovery and development of pharmaceutical products using its proprietary LEAPTM (Ligand Evolution to Active Pharmaceuticals) technology. The company is currently targeting the treatment of prostate cancer, endometriosis and Alzheimer’s disease.